| Sources | Names Used |
|---|---|
| GDSC1000 | MPS-1-IN-1 |
| PharmacoGx | MPS-1-IN-1 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RELB | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | TM6SF1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | OXR1 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | NEUROG2 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | ZNF438 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | RAB11FIP1 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | MRPS27 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | RPA2 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | GNAI1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | CSNK1E | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
